Numinus Wellness (NUMIF) News Today C$0.03 +0.00 (+0.33%) (As of 12/20/2024 05:55 PM ET) Add Compare Share Share Headlines Stock AnalysisChartHeadlinesShort Interest All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Numinus Wellness Inc. (NUMI.TO)December 18, 2024 | ca.finance.yahoo.comNuminus Wellness Closes Sale of Clinics and Launches Initiative to Increase Access to Mental Health CareDecember 17, 2024 | prnewswire.comNuminus Provides Bi-Weekly Update on Annual FilingsDecember 16, 2024 | prnewswire.comRising High: Numinus Wellness to sell five Utah clinics for $3.53MNovember 22, 2024 | markets.businessinsider.comNuminus Applies for Management Cease Trade OrderNovember 15, 2024 | prnewswire.comNuminus sells clinics to Stella, partners on mental health techNovember 15, 2024 | msn.comNuminus Wellness Announces Sale of Clinics and Unique Data Partnership to Increase Access to Mental Health CareNovember 15, 2024 | prnewswire.comNuminus Wellness Inc. (LR23.F)September 18, 2024 | ca.finance.yahoo.comCompass Pathways: Sector-Wide Reality Check Needed Post FDA Lykos MDMA DecisionAugust 21, 2024 | seekingalpha.comNuminus Wellness Inc.: Numinus Wellness Comments on FDA Decision on New Drug Application for MDMA-Assisted Therapy for PTSDAugust 13, 2024 | finanznachrichten.deNuminus Wellness Comments on FDA Decision on New Drug Application for MDMA-Assisted Therapy for PTSDAugust 12, 2024 | prnewswire.comNuminus Wellness Inc. Announces Third Quarter Fiscal 2024 ResultsJuly 11, 2024 | prnewswire.comNuminus to Host Q3 Fiscal 2024 Results Conference Call on July 11, 2024July 10, 2024 | prnewswire.comNuminus to Host Q3 Fiscal 2024 Results Conference Call on July 11, 2024July 10, 2024 | prnewswire.comNuminus Wellness Announces Resignation of DirectorJune 24, 2024 | prnewswire.comNuminus Wellness Announces Strategic Acquisition of MedBright AIJune 20, 2024 | prnewswire.comNuminus Wellness Comments on FDA Advisory Committee Meeting for Investigational MDMA-Assisted Therapy for PTSDJune 7, 2024 | prnewswire.comNuminus Wellness Announces Voting Results From its Annual General Meeting of ShareholdersMay 31, 2024 | prnewswire.comNuminus Wellness Receives Health Canada Approval for Study into Group Model for MDMA-Assisted TherapyMay 30, 2024 | prnewswire.comNuminus Wellness Focused on Boosting Profitability and Expanding Community SupportMay 7, 2024 | prnewswire.comEarnings call: Numinus Wellness reports Q2 fiscal 2024 resultsApril 18, 2024 | uk.investing.comNuminus Wellness Inc.: Cedar Clinical Research selected as clinical research site for Cybin's Phase 3 Study of CYB003April 17, 2024 | finanznachrichten.deCedar Clinical Research selected as clinical research site for Cybin's Phase 3 Study of CYB003April 17, 2024 | finance.yahoo.comNuminus Wellness Q2 2024 Revenue Declines Amid Clinic Reshuffling And Expected Industry TrendsApril 15, 2024 | benzinga.comNuminus Wellness Shares Down on Canadian Operations ReorganizationApril 15, 2024 | marketwatch.comNuminus Wellness Provides Corporate UpdateApril 15, 2024 | prnewswire.comNuminus Wellness Inc. Announces Second Quarter Fiscal 2024 ResultsApril 12, 2024 | prnewswire.comNuminus to Host Q2 Fiscal 2024 Results Conference Call on April 15, 2024April 9, 2024 | prnewswire.comOnconova slips after all-stock merger with TrawsfynyddApril 2, 2024 | msn.comTrump Media Goes Public Via SPAC DealMarch 28, 2024 | ca.finance.yahoo.comPharmAla Biotech Signs Sale Agreement with NuminusMarch 26, 2024 | finance.yahoo.comPharmAla Biotech signs sale agreement with Numinus WellnessMarch 26, 2024 | msn.comNuminus Wellness Submits Clinical Trial ApplicationMarch 20, 2024 | prnewswire.comNuminus Wellness Inc.: Numinus Wellness Provides Corporate UpdateMarch 12, 2024 | finanznachrichten.deNuminus Wellness Provides Corporate UpdateMarch 12, 2024 | prnewswire.comNUMIF Numinus Wellness Inc.March 1, 2024 | seekingalpha.comNuminus CEO Reflects On Monumental Achievement: FDA's Acceptance Of MDMA Therapy ApplicationFebruary 23, 2024 | msn.comThis May be One of the Biggest Catalysts for Psychedelic Stocks in 2024February 16, 2024 | theglobeandmail.comNuminus Wellness Inc. Closes $6 Million Bought Deal Public OfferingFebruary 16, 2024 | finance.yahoo.comNuminus Wellness Inc. Announces $6 Million Bought Deal Public Offering with Leads Orders from MAPS and Integrated V.C.February 1, 2024 | finance.yahoo.comNuminus Wellness Divests of Holdings in Alto Neuroscience Inc.February 1, 2024 | finance.yahoo.comNuminus Wellness Continues Tight Expense Management With Strategic Reviews UnderwayJanuary 18, 2024 | msn.comNuminus Wellness Inc. Announces First Quarter Fiscal 2024 ResultsJanuary 15, 2024 | finance.yahoo.comNuminus to Host Q1 Fiscal 2024 Results Conference Call on January 15, 2024January 2, 2024 | finance.yahoo.comCedar Clinical Research selected as clinical research site for Beckley Psytech's Phase 2b StudyDecember 15, 2023 | finance.yahoo.comStocks in play: Numinus Wellness Inc.December 13, 2023 | ca.finance.yahoo.comNuminus Congratulates MAPS on its Application to the FDA for MDMA-Assisted Therapy for PTSDDecember 13, 2023 | finance.yahoo.comNuminus Reports Q4 & Full Year Fiscal 2023 Results, Including Greatly Reduced Cash Burn RateNovember 30, 2023 | benzinga.comNuminus Wellness Inc. Announces Fourth Quarter and Full Year Fiscal 2023 ResultsNovember 29, 2023 | finance.yahoo.comNuminus to Host Q4 2023 and Annual Results Conference Call on November 29, 2023November 21, 2023 | finance.yahoo.com Get Numinus Wellness News Delivered to You Automatically Sign up to receive the latest news and ratings for NUMIF and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s Sending THIS Crypto Higher on Purpose (Ad)Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW NUMIF Media Mentions By Week NUMIF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NUMIF News Sentiment▼0.290.60▲Average Medical News Sentiment NUMIF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NUMIF Articles This Week▼30▲NUMIF Articles Average Week Get Numinus Wellness News Delivered to You Automatically Sign up to receive the latest news and ratings for NUMIF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies American Oncology Network News CareRx News Extendicare News Life Healthcare Group News Medical Facilities News Orpea News P3 Health Partners News Raffles Medical Group News Ramsay Health Care News Sienna Senior Living News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:NUMIF) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Numinus Wellness Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Numinus Wellness With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NUMIF Stock Alerts